Differentiated therapy with prostaglandin E1 (alprostadil) after orthotopic liver transplantation: The usefulness of procalcitonin (PCT) and hepatic artery resistive index (RI) for the evaluation of early graft function and clinical course

Clinical Chemistry and Laboratory Medicine

Volumn 38, Issue 11, 2000, Pages 1177-1180

  Kornberg, A ^a   Grube, T ^a   Wagner, T ^a   Voigt, R ^a   Homman, M ^a   Schotte, U ^a   Schmidt, K ^a   Scheele, J ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Ischemic reperfusion injury; Procalcitonin; Prostaglandin; Resistive index

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; PROCALCITONIN; PROSTAGLANDIN E1;

ADULT; ALLOGRAFT; AMINOTRANSFERASE BLOOD LEVEL; ARTERY RESISTANCE; ARTICLE; CLINICAL TRIAL; COLOR ULTRASOUND FLOWMETRY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; EVALUATION; FEMALE; HEPATIC ARTERY; HUMAN; LIVER CELL DAMAGE; LIVER FUNCTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PARAMETER; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REPERFUSION INJURY; TREATMENT INDICATION;

ALPROSTADIL; CALCITONIN; GRAFT SURVIVAL; HEPATIC ARTERY; HUMANS; LIVER TRANSPLANTATION; PROTEIN PRECURSORS; TRANSAMINASES; VASCULAR RESISTANCE;

EID: 0034521241     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2000.182     Document Type: Article

References (26)

1. Present status and future prospects in liver transplantation
2. Living-donor liver transplantation in adults
3. Risk factors for primary dysfunction after liver transplantation in the University of Wisconsin solution era
4. Effects of prostaglandin E1 on the recovery of ischemia-induced liver mitochondrial dysfunction in rats with cirrhosis
5. Hepatocyte membrane stabilization by prostaglandins E1 and E2: Favorable effects on rat liver injury
6. In vivo and in-vitro effects of arachidonic acid products on liver cell integrity following carbon tetrachloride poisoning
7. Inhibition of viral replication in cell cultures treated with prostaglandin E1
8. Preconditioning of donor livers with prostaglandin 12 before retrieval decreases hepatocellular ischemia-reperfusion injury
9. A double-blind randomized placebo-controlled trial of prostaglandin E1 in liver transplantation
10. Prostaglandin E1 administration following orthotopic liver transplantation: A randomized prospective multicenter trial
11. Risk factors for primary dysfunction after liver transplantation: A multivariate analysis
12. Treatment of primary liver graft non-function with prostaglandin E1
13. Sinusoidal lining cell damage: The critical injury in cold preservation of liver allografts in the rats
14. Liver cytoprotection by prostaglandins
15. Cytoprotective actions of protacyclin during hypoxia in the isolated perfused cat liver
16. Prophylactic administration of prostaglandin E1 in liver transplantation: Results of a pilot trial
17. Duplex Doppler ultrasonography for monitoring liver transplants
18. Doppler ultrasound of the hepatic artery and vein performed daily in the first two weeks after orthotopic liver transplantation - Useful for the diagnosis of acute rejection
19. Procalcitonin and its component peptides in systemic inflammation: Immuno-chemical characterizstion
20. Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis related cytokines in vitro
21. Ischemia/reperfusion injury and organ failure
22. Procalcitonin after extracorporeal circulation. Synthesis in the hepatosplanchnic region
23. Liver ischemia and reperfusion induces a systemic inflammatory response through Kupfer cell activation
24. Protective effect of liver ischemic preconditioning on liver and lung injury induced by hepatic ischemia-reperfusion in the rat
25. Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis
26. Procalcitonin moduliert die proinflammatorische Freisetzung in vitro